Judd WR - Search Results

1

Impact of real-time notification of Clostridium difficile test results and early initiation of effective antimicrobial therapy.

Polen CB, Judd WR, Ratliff PD, King GS. Polen CB, et al. Among authors: judd wr. Am J Infect Control. 2018 May;46(5):538-541. doi: 10.1016/j.ajic.2017.11.010. Epub 2018 Jan 3. Am J Infect Control. 2018. PMID: 29305281

2

Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa-infected patients.

Judd WR, Ratliff PD, Hickson RP, Stephens DM, Kennedy CA. Judd WR, et al. Am J Infect Control. 2016 Nov 1;44(11):1275-1279. doi: 10.1016/j.ajic.2016.04.218. Epub 2016 Jun 16. Am J Infect Control. 2016. PMID: 27320901

3

Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections.

Wang SS, Ratliff PD, Judd WR. Wang SS, et al. Among authors: judd wr. Int J Clin Pharm. 2018 Feb;40(1):143-149. doi: 10.1007/s11096-017-0560-1. Epub 2017 Nov 17. Int J Clin Pharm. 2018. PMID: 29147962

4

Assessing mortality outcomes of beta-lactam-allergic patients presenting with sepsis.

Komyathy KL, Judd WR, Ratliff PD, Hughes RE. Komyathy KL, et al. Among authors: judd wr. Am J Emerg Med. 2020 Sep;38(9):1816-1819. doi: 10.1016/j.ajem.2020.05.032. Epub 2020 May 17. Am J Emerg Med. 2020. PMID: 32738475

5

Assessing the impact of CKD on outcomes in septic shock patients receiving standard Vs reduced initial fluid volume.

Rice DM, Ratliff PD, Judd WR, Kseibi SA, Eberwein KA. Rice DM, et al. Among authors: judd wr. Am J Emerg Med. 2020 Oct;38(10):2147-2150. doi: 10.1016/j.ajem.2020.07.055. Epub 2020 Jul 27. Am J Emerg Med. 2020. PMID: 33046295

6

Combination therapy for disseminated strongyloidiasis with associated vancomycin-resistant, linezolid-intermediate Enterococcus faecium meningitis: A case report.

Tobin MA, Dougherty DF, Ratliff PD, Judd WR. Tobin MA, et al. Among authors: judd wr. J Clin Pharm Ther. 2022 Jan;47(1):121-124. doi: 10.1111/jcpt.13448. Epub 2021 Jun 2. J Clin Pharm Ther. 2022. PMID: 34075617

7

Evaluation of an alternative extended-infusion piperacillin-tazobactam dosing strategy for the treatment of gram-negative infections.

Winstead EM, Ratliff PD, Hickson RP, Mueller JE, Judd WR. Winstead EM, et al. Among authors: judd wr. Int J Clin Pharm. 2016 Oct;38(5):1087-93. doi: 10.1007/s11096-016-0334-1. Epub 2016 Jun 22. Int J Clin Pharm. 2016. PMID: 27333796

8

Implementation of an adult code sepsis protocol and its impact on SEP-1 core measure perfect score attainment in the ED.

Whitfield PL, Ratliff PD, Lockhart LL, Andrews D, Komyathy KL, Sloan MA, Leslie JC, Judd WR. Whitfield PL, et al. Among authors: judd wr. Am J Emerg Med. 2020 May;38(5):879-882. doi: 10.1016/j.ajem.2019.07.002. Epub 2019 Jul 2. Am J Emerg Med. 2020. PMID: 31301874

9

False-negative cerebrospinal fluid fungal culture results following oral antineoplastic therapy with a 5-fluorouracil derivative.

Judd WR, Shely RN, Ratliff PD, Reymann MT. Judd WR, et al. J Clin Pharm Ther. 2015 Dec;40(6):696-8. doi: 10.1111/jcpt.12326. Epub 2015 Oct 12. J Clin Pharm Ther. 2015. PMID: 26456089

10

Impact of a pharmacist-led pneumococcal vaccine compliance program.

King GS, Judd WR. King GS, et al. Among authors: judd wr. Am J Health Syst Pharm. 2017 Dec 1;74(23):1948-1952. doi: 10.2146/ajhp160916. Am J Health Syst Pharm. 2017. PMID: 29167136 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters